Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DX25FVJGN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,889
Award facts
- Contract value 100% obligated
- $11,889.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 tablets. This $11,889.42 firm fixed-price delivery order, with completion scheduled for August 27, 2025, represents a competitively awarded non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including brand-name and generic medications, vaccines, and specialized medical devices. XELJANZ XR is a targeted immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, reflecting the type of specialty medications supported through the DLA's pharmaceutical vendor program.
Quick answers
Who was awarded contract SPE2DX25FVJGN?
SPE2DX25FVJGN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 26, 2025.
How much is contract SPE2DX25FVJGN worth?
The government has obligated $11,889 on SPE2DX25FVJGN.
Is contract SPE2DX25FVJGN an order under another contract?
Yes. SPE2DX25FVJGN is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJGN competed?
The extent of competition for SPE2DX25FVJGN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award